Insulin is a peptide hormone produced primarily by beta cells in the pancreatic islets. Its central role is to coordinate nutrient metabolism, particularly after a meal when blood glucose concentrations rise. Insulin promotes glucose uptake and utilisation in several tissues, stimulates storage of nutrients and suppresses processes that increase circulating glucose. It is therefore one of the major hormones maintaining blood glucose homeostasis. Insulin does not simply remove glucose from the blood.
It changes the metabolic state of tissues by influencing carbohydrate, fat and protein metabolism. Its effects are particularly prominent in skeletal muscle, adipose tissue and liver, although different tissues respond in different ways. Insulin secretion is regulated by blood glucose and by other nutrient and hormonal signals. The hormone acts through a specific cell surface receptor that initiates intracellular signalling pathways controlling enzymes, transport proteins and gene expression.
Insulin is synthesised as a precursor protein and processed through stages that produce mature insulin and C peptide. Beta cells store insulin in secretory granules and release it when appropriate stimuli occur. Rising blood glucose is a major stimulus. Glucose enters beta cells and is metabolised, increasing the cellular ATP to ADP ratio. This contributes to closure of ATP sensitive potassium channels, membrane depolarisation, opening of voltage dependent calcium channels and calcium dependent exocytosis of insulin containing granules.
Insulin secretion is also influenced by amino acids, gastrointestinal hormones and neural signals. The rapid and regulated nature of insulin release allows the body to respond to changes in nutrient availability. The relationship between glucose concentration and insulin secretion is dynamic, and secretion normally occurs in pulses rather than as a completely constant output.
One major action of insulin is to promote glucose uptake into skeletal muscle and adipose tissue. It does this largely by stimulating movement of glucose transporter type 4, commonly called GLUT4, from intracellular storage compartments to the cell surface. More GLUT4 at the membrane increases facilitated diffusion of glucose into these cells. Insulin also promotes glucose storage as glycogen in liver and muscle, although its actions differ between these tissues.
In the liver, insulin suppresses glucose production through pathways including gluconeogenesis and glycogen breakdown. These actions help prevent excessive rises in blood glucose after carbohydrate consumption. The brain and some other tissues have glucose transport systems that are less dependent on insulin, which is another reason it is inaccurate to say that insulin simply allows all body cells to take up glucose.
Insulin strongly influences fat metabolism. When insulin is abundant, it promotes storage of energy and suppresses lipolysis, the breakdown of stored triglycerides in adipose tissue. It promotes pathways favouring fatty acid and triglyceride synthesis when energy and substrate availability are high. By inhibiting excessive release of fatty acids from adipose tissue, insulin helps shift metabolism towards nutrient storage after feeding.
Low insulin availability, particularly when combined with elevated counterregulatory hormones, has the opposite metabolic tendency and promotes mobilisation of stored fat. In severe insulin deficiency, excessive fatty acid breakdown can contribute to production of ketone bodies and potentially to diabetic ketoacidosis. Thus insulin is not merely a glucose hormone. It is a major regulator of the body's transition between nutrient storage and nutrient mobilisation.
Insulin also affects protein metabolism. In skeletal muscle and other tissues, insulin promotes amino acid uptake and supports protein synthesis while generally reducing protein breakdown. Its anabolic effects therefore extend across carbohydrates, fats and proteins. Insulin works together with other hormones, including glucagon, adrenaline, cortisol and growth hormone, which can have opposing or complementary metabolic effects depending on the physiological situation.
Glucagon is particularly important in fasting because it promotes hepatic glucose production and helps maintain blood glucose when dietary nutrients are unavailable. The relative concentrations of insulin and glucagon therefore help determine whether the body is in a storage or mobilisation state. This relationship is sometimes more informative metabolically than considering either hormone in isolation.
Insulin acts through the insulin receptor, which is a receptor tyrosine kinase located on the surface of target cells. When insulin binds, the receptor undergoes structural and enzymatic changes that activate intracellular signalling pathways, including pathways involving insulin receptor substrates, phosphoinositide 3 kinase and Akt. These pathways influence GLUT4 trafficking, glycogen synthesis, lipid metabolism, protein synthesis and other cellular processes. Insulin signalling can be modified by cellular stress, inflammation, excess lipid accumulation and other factors. In insulin resistance, target tissues respond less effectively to a given insulin concentration, so the pancreas may initially compensate by secreting more insulin. Over time, beta cell dysfunction can contribute to persistent hyperglycaemia. This mechanism is central to the pathophysiology of type 2 diabetes.
In type 1 diabetes, immune mediated destruction of pancreatic beta cells results in severe deficiency of endogenous insulin production. People with type 1 diabetes therefore require insulin replacement to regulate metabolism and prevent dangerous metabolic consequences. Type 2 diabetes generally involves a combination of insulin resistance and progressive beta cell dysfunction, although the relative contributions vary among individuals. Other forms of diabetes can arise from genetic, pancreatic, hormonal, medication related or other causes.
Measuring blood glucose and related metabolic markers helps assess glucose regulation, while treatment depends on the type and individual circumstances. Insulin therapy itself can cause hypoglycaemia if the amount of circulating insulin exceeds physiological needs relative to available glucose. Understanding insulin therefore requires considering both its normal functions and the consequences of too little or ineffective signalling.
Insulin is best understood as a central anabolic and homeostatic hormone that coordinates the body's response to nutrient availability. Its actions reduce excessive circulating glucose after meals, promote nutrient storage and support synthesis of glycogen, lipid and protein. At the same time, it suppresses metabolic pathways that would otherwise release stored fuels. Insulin does not operate alone because glucagon, catecholamines, cortisol, growth hormone and local metabolic signals contribute to the overall regulation of energy balance. Its importance extends from minute to minute control of blood glucose to long term effects on metabolism and tissue physiology. The hormone provides a clear example of how endocrine signalling integrates nutrient sensing, cellular receptors, intracellular pathways and whole body homeostasis.
